Elad Aharonson on M&A strategy
From ICL Investor Day October 2022 · · ICL Group
“We are targeting timely opportunities for strategic M A's... we're going to be even more aggressive than we were in terms of our targets for the next five years and we're targeting the Americas for uh for inorganic growth so that would be South America and North America America.”
On , Elad Aharonson, President & CEO at ICL Group, spoke about M&A strategy during ICL Investor Day October 2022 on ICL Group.
About Elad Aharonson
At ICL's October 2022 Investor Day, President and CEO Elad Aharonson stated that the company had already reached its 2025 targets two years early, attributing this to successful acquisitions in Brazil and their integration. He noted that Brazil, China, and India account for 70 percent of growth in the specialty plant nutrition market, and said ICL is focused on those countries. Aharonson outlined new targets for 2027, aiming for $4.25 billion in sales and EBITDA of more than $750 million, with the goal of becoming the global leader in specialty plant nutrition. He also said that in a normal year, EBITDA would track around 15 percent, with the underlying business growing margins over time despite commodity impacts.